Wednesday, March 18, 2015

Antigen Express on Cancer Immunotherapy and Peptides

In today's featured interview from TIDES 2014, Eric von Hofe, Ph.D., President, Antigen Express, Inc. discusses peptides, cancer immunotherapy, peptide vaccines, and his experience at the TIDES 2014 event. He states that peptides constitute the minimum unit required to generate in response to solid advantages when developing therapeutic materials and that peptides “rev-up” the immune system to go out to be specific canto cells. Do you want to learn more? Watch this interview:

TIDES 2015 will take place May 3-6, 2015 in San Diego, California.  At this year's event, we're offering two days of content focusing on Peptide Chemistry Manufacturing and Controls and Peptide Discovery, Preclinical and Clinical featuring insights from companies such as PolyPeptide Group, Amgen, NOXXON Pharma, Zealand Pharma and more. For more this year's program by downloading the agenda.  As a reader of this blog, when you register to join us and mention code XB15180BLOG, you can save 20% off standard rates.

Share this article with your social network, just click below to share now!

No comments :

Post a Comment